Navigation Links
PRA International Experts to Speak at Industry Events
Date:3/23/2011

RALEIGH, N.C., March 23, 2011 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces that two of our experts will be speakers at the upcoming Partnerships in Clinical Trials and Late Phase Drug Development conferences. PRA will also be exhibiting at both conferences.

Mike Hill, Project Manager for PRA's Late Phase Services group, will make a presentation at the Late Phase Drug Development conference in Boston, MA on 23 March at 11:10 AM EDT. Mr. Hill will discuss the application of statistics to post-marketing studies in his speech, "Utilizing Statistical Techniques to Drive Late Phase Operations". Attendees can learn more about our late phase and other services at our exhibition booth.

Mr. Hill has over six years of experience working with global registries and observational studies. He has designed and managed large-scale disease, drug and diagnostic registries across multiple therapeutic areas. PRA's Late Phase Services group supports global and regional post-approval studies with management locations centralized in our Horsham, Pennsylvania and Mannheim, Germany offices.

Kent Thoelke, Senior Vice President of PRA's Scientific and Medical Affairs group, will present at Partnerships in Clinical Trials being held in Phoenix, Arizona on 31 March at 2:15 PM PDT. He will discuss collaborative models that sponsors, CROs and investigative sites are pursuing to improve efficiencies and reduce costs in his session, "Strategic Sponsor-Site Partnership Models: Improving Site Selection and Recruiting in a Collaborative Environment". PRA representatives will also be available at Booth #1200 to discuss our experience in supporting clinical trials.

With over 19 years of experience in all aspects of global drug development, Mr. Thoelke has particular expertise in the execution of global studies. In his role at PRA, he provides scientific and strategic oversight of product development to support project teams and client development plans. PRA's Scientific and Medical Affairs team covers a broad range of therapeutic areas, providing support across all phases of drug development.

About PRA

PRA conducts clinical trials across all therapeutic areas in more than 80 countries and provides services in all phases of clinical development through its 39 global offices.

PRA's therapeutic expertise, global reach and project experience combined with its extensive local knowledge and differentiating philosophy—THE PERSONAL ELEMENT—enable its project teams to deliver consistent and on-time performance. This unique PRA philosophy recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to be innovative and to use their personal commitment to accelerate the development life cycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: ... and sells medical devices and wearable sleep respiratory products ... cooperation agreement with Hongyuan Supply Chain Management Co., Ltd. ... 20, 2016, to develop Dehaier,s new Internet medical technology ... will leverage Hongyuan Supply Chain,s sales platform to reach ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
Breaking Medicine News(10 mins):